Norges Bank
BIVV

Norges Bank’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Norges Bank’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,559,061
Closed -$84.1M – 2189
2017
Q4 		$84.1M Buy
1,559,061
+431,369
+38% +$23.6M 0.03% 544
2017
Q3 		$64.4M Sell
1,127,692
-44,943
-4% -$2.63M 0.02% 645
2017
Q2 		$70.6M Sell
1,172,635
-179,729
-13% -$10.2M 0.03% 573
2017
Q1 		$73.7M Buy
+1,352,364
New +$66.6M 0.03% 531

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Norges Bank's BIVV Position: Q1 2018 in Review

Norges Bank sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,559,061 shares — an estimated $84.1M sold.

Norges Bank first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $84.1M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Norges Bank reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Norges Bank sold 1,559,061 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $84.1M.
  • Norges Bank first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Norges Bank's Bioverativ Inc. Common Stock position peaked at $84.1M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Norges Bank's 13F filing for Q1 2018, filed 9 May 2018.